Battle Card: Character Biosciences $17M Series B Trigger
Character Biosciences locks in $17M Series B extension. Target Cheng Zhang with data integration & AI modeling pitch. Nail the next touch. Fuel your pipeline and commission.
Published on
Do not index
Do not index
🚀 Battle Card: Character Biosciences
Quick trigger:
👤 Decision Maker in the News
- [Cheng Zhang](), CEO & Co-Founder 📧 cheng@characterbio.com
💡 Why It Matters
- As a Character Biosciences sales trigger, the Series B top-up to $110M+ validates the push to accelerate AI-driven precision therapies for dry AMD and POAG. → Source
🎯 Core Pain Point
- High failure rates in polygenic disease drug development
- Limited access to integrated genomics–clinical datasets
💰 What to Pitch
- Primary: Data integration & management platform → Streamline clinical-genomic data workflows
- Expansion: Predictive AI modeling suite → Improve target validation accuracy
🗺️ Quick Context
- HQ: Jersey City, NJ
- Employees: ≈ 50
- Rev: ≈ $5 M
- Website: characterbio.com
🤼 Competitive Intel
Which other vendors you’ll probably face to win Character Biosciences’s business.
- Tempus — Genomics & AI Analytics
- Unique edge: Ultra-high-throughput sequencing & clinical AI models
- Evaluated by CEO & Head of R&D for model robustness
- Cota Healthcare — Real-World Data Platform
- Unique edge: Integrated EHR & outcomes datasets
- Evaluated by VP Clinical Ops for dataset quality
- Owkin — AI & Federated Learning
- Unique edge: Privacy-preserving multi-center model training
- Evaluated by CTO & Data Science lead for scalability
- Syapse — Real-World Evidence
- Unique edge: Proven oncology-to-ophthalmology crossover frameworks
- Evaluated by Head of Medical Affairs for regulatory support
✅ Do-Now Checklist
Reference the Character Biosciences sales trigger in your first email to Cheng Zhang
Generate email + DM with the Copy-My-Prompt block (Step 7) and send first touch
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
Get Character Biosciences sales trigger intel like this daily—no fluff, all pipeline.
Subscribe to NewsletterForLeads
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑❑
OFFER_BRIEF = ❑Data integration & management platform❑
PROOF_METRIC = ❑≈ TBD❑
CTA_STYLE = ❑quick_call❑
TONE = ❑punchy❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Cheng
COMPANY = Character Biosciences
DEPT = R&D
SIZE = 50
BOTTLENECK = high failure rates
EVENT = 17M Series B Extension
DETAIL = the $17M Series B extension
PAIN = high failure rates in polygenic disease drug development
SRC = https://vcnewsdaily.com/character-biosciences/venture-capital-funding/lfgmsbfctj
SIM_CO = ≈ TBD
WIN_METRIC = ≈ TBD
NEXT_SIZE = ≈ TBD
EMP_EST = ≈ 50
REV_EST = ≈ $5M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: 50-person R&D
Cheng—noticed your R&D team is ≈ 50.
That’s when high failure rates slows growth.
We helped ≈ TBD fix this with Data integration & management platform.
Result: ≈ TBD.
Quick call?
PS—next bottleneck hits ≈ ≈ TBD.
DM ≤45 words, TONE:
Saw your post about the $17M Series B extension — high failure rates in polygenic disease drug development.
Data integration & management platform. ≈ TBD.
Quick chat?